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In this issue of Immunity, Li et al. (2011) reported a dynamic protein interactome network underlying antiviral
innate immune response and established the role of Mind Bomb proteins in the anti-RNA viral innate immune
response.Immune responses are orchestrated by
a large number of genes and their prod-
ucts, RNAs, and proteins. Pattern recog-
nition receptors, such as Toll-like recep-
tors (TLRs) and RIG-I-like receptors
(RLRs), and signaling molecules, such as
adaptor proteins MyD88, TRIF, IPS-1,
and STING, have been identified and their
roles have been elucidated (Kumagai and
Akira, 2010). These proteins are known to
interact with one another, forming com-
plexes and working to signal invasion of
pathogens and evoke immune responses.
In this issue of Immunity, Shitao Li, Martin
Dorf, and their colleagues (Li et al., 2011)
provided a dynamic network view of pro-
teins involved in antiviral responses.
Such protein-protein interactions (PPIs)
are involved not only with immune re-
sponses but also other biological pro-
cesses. Identification of the specific inter-
acting partners of a protein of interest
helps to elucidate proteins involved in
a biological process. Yeast two-hybrid
(Y2H) screening provides a useful method
for identifying PPIs. In addition, Y2H can
identify novel proteins, called prey pro-
teins, bound to the bait protein of interest.
With this method, many proteins and PPIs
involved in innate immune responses
have been identified. Another method for
the identification of proteins is throughthe use of a combination of affinity purifi-
cation or co-immunoprecipitation (coIP)
and mass spectrometry (MS).
Recently, researchers have revealed
the roles of genes in immune responses.
However, given that a mammalian cell
may contain more than 130,000 PPIs,
only a fraction have been identified. This
set of molecular interactions in a cell,
often called the ‘‘interactome’’ (Venkate-
san et al., 2009), provides the basis for
one of the most important goals of current
postgenomic biology: to map the interac-
tome systematically. Early efforts to map
PPIs were done with Y2H methods. For
an immunology-related example of an
Y2H mapped interactome, a recent study
identified the MAP kinase interactome
(Bandyopadhyay et al., 2010). Over
2,000 interactions between MAP kinase-
related proteins and other proteins were
identified. Another method, coIP-MS, has
also been utilized for mapping the interac-
tome and has been made more realistic
through recent improvements in proteo-
mics techniques. The TNF-a-NF-kB path-
way was targeted, and over 200 interac-
tions and 80 unique interacting proteins
were identified (Bouwmeester et al.,
2004). The autophagy system, the deubi-
quitinases, and the epigenetic histone
marks and their readers, were also sub-jected tomapping of their network organi-
zation (reviewed in Cox and Mann, 2011).
The study by Li et al. (2011) employed
the coIP-MS method and mapped the
dynamic interactome of antiviral signaling
leading to type I interferon (IFN) produc-
tion. Baits were selected from the list of
known proteins involved in antiviral sig-
naling. The authors identified 401 unique
interactions between 58 bait proteins
and 260 interacting proteins. They con-
firmed interactions between RIG-I or
MDA5 and IPS-1, IPS-1 and TBK1, and
STING and TBK1, among others. In total,
71out of the401 interactionswere interac-
tions that had been already reported, and
the other 330 interactions were unique.
Although Y2H provides a binary and
static view of an interactome, coIP-MS is
useful for mapping dynamic interactions.
This is advantageous for mapping the in-
teractome of a dynamic system, including
immune systems. Li et al. (2011) also
mapped PPIs under stimulation with
several ligands such as double-stranded
RNA, DNA, and viruses. They found
approximately one-fifth of the interactions
were up- or downmodulated by ligands.
These interactions were confirmed by an
in vitro IP assay, and some interactions
were further confirmed as being ligand
inducible, such as the TBK1-Mind Bomb
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Figure 1. Regulation of RNA Virus Signaling by Mind Bomb
Invading RNA virus is detected by cytoplasmic RLR. The signaling facilitates the interaction betweenMind
Bomb (MIB) and TBK1.MIB in turn K63-ubiquitinates and activates TBK1. Activated TBK1 phosphorylates
IRF3 and induces the transcription of genes such as Ifnb1, Cxcl10, and Ccl5. In contrast, Nrdp1 serves as
an ubiquitinase for TBK1 in the case of the LPS stimulated TLR4 signaling pathway.
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Previews1 (MIB1) interaction, which was enhanced
after RNA virus infection.
Interacting partners are not necessarily
functional in the biological process. Li
et al. (2011) further confirmed the role of
proteins identified in the antiviral signaling
pathway by employing both a gain of
function experiment and a siRNA gene
targeting experiment. They checked viral
dissemination and activation of NF-kB,
ISRE, and IFN-b luciferase reporters and
IFN-b production upon viral infection.
The roles of several gene products were
established. For instance, FOXK1 and
FOXK2 interacted with IRF2 and inhibited
IFN-b production upon RNA virus in-
fection when overexpressed, whereas
CtBP1 and CtBP2 inhibited IFN-b produc-
tion upon DNA virus infection. MIB1,
which interacted with TBK1 and NAP1,
activated NF-kB and ISRE reporters and
suppressed RNA virus dissemination,
whereas gene targeting of MIB1 en-
hanced viral replication and inhibited IFN
production upon RNA virus infection.
Li et al. (2011) chose MIB1 for further
characterization of the antiviral response
(Figure 1). MIB1 has one homolog, MIB2,
whose overexpression also activated
NF-kB and ISRE reporters, indicating
functional redundancy of MIB proteins.
MIB proteins have multiple RING finger
motifs homologous to several E3 ubiquitin
ligases, suggesting that MIB proteins actas an ubiquitinase of TBK1. The authors
confirmed the K63-type ubiquitination of
TBK1 upon RNA virus infection and
in vitro ubiquitination of TBK1 by MIB1
and MIB2, but not by a MIB2 ligase
mutant. MIB1 and MIB2 doubly deficient
embryonic fibroblasts were unable to
induce TBK1 ubiquitination, further indi-
cating the ubiquitin ligase role of MIB1
and MIB2. This ubiquitination is impor-
tant for the activation of TBK1-dependent
gene expression because co-overexpres-
sion of TBK1 and MIB1 or MIB2 aug-
mented Ifnb1 andCcl5mRNA expression,
whereas the that of MIB2 mutant did not.
Deficiency of MIB1 and MIB2 impaired
TBK1- and IPS-1-dependent ISRE activa-
tion, IRF3 phosphorylation, and Ifnb1,
Cxcl10, and Ccl5 mRNA expression. In
contrast, activation of NF-kB was not im-
paired. Consistently, Tnf and Il6 mRNA
expressions were not impaired, suggest-
ing that MIB1 and MIB2 specifically
modulate the TBK1-IRF3 pathway. Upon
other stimulations, such as DNA virus
infection or LPS, loss of MIB1 and MIB2
did not impair Cxcl10 or Ccl5 mRNA
expression. Fibroblasts doubly deficient
for MIB1 and MIB2 showed higher RNA
viral replication. Interestingly, the results
also showed that Nrdp1, another ubiquitin
ligase (Wang et al., 2009), was specifically
involved in LPS-elicited Ifnb1 and Cxcl10
mRNA expression (Figure 1). These re-Immunity 35, Sesults collectively suggest that MIB1 and
MIB2 selectively regulate the TBK1-IRF3
pathway upon RNA virus infection.
The work of Li et al. (2011) provided a
network view of the antiviral innate immu-
nity interactome and established the role
of MIB1 and MIB2 E3 ubiquitin ligases in
the TBK1-IRF3 axis of anti-RNA viral im-
mune type I IFN responses. However,
dynamics of identified PPIs and their
roles in antiviral responses largely remain
toberesolved.Futurestudiesshould inves-
tigate how the specificity ofMIB proteins is
determined. In addition, the dynamics of
several identified interactions may be ex-
plained by other information. For example,
spatiotemporal regulation of proteins
may account for the dynamics of some
interactions. Formation of the ATG9A-
STING interaction after double-stranded
DNA stimulation could have been an
example identified in the current study
because ATG9A and STING are colocal-
ized after the stimulation (Saitoh et al.,
2009). Integrating such information into
the interactome map will lead to a deeper
understanding of the system.Moreover, in-
teractomesmay differ between various cell
types under different stimulations. Most of
the coIP-MS interactome mapping studies
have been performed in cell lines such as
HEK293 cells and HeLa cells, although in
the case of the study by Li et al. (2011),
they provided evidence that MIB proteins
have the same roles in bone marrow-
derived macrophages. They showed that
macrophages have relatively higher
expression of Mib2 than HEK293 or fibro-
blasts and thus deletion of only MIB1 or
MIB2 were insufficient to impair antiviral
responses. The use of primary cells in
future studies will be important.
Interactome mapping provides a sys-
tems picture of a cellular process. Inte-
gration of multiple data, however, is
obligatory for gaining a holistic view of a
process, which is the ultimate goal of sys-
tems biology. In that sense, other large-
scale technologies such as transcriptome
analysis may complement an interactome
study. Furthermore, study of not only PPIs
but also interactions between proteins,
nucleic acids, and lipids will become
important for the understanding of im-
mune systems, although there are still
technical limitations. Nonetheless, the
current study by Li et al. (2011) lays a foun-
dation for future developments in systems
research of antiviral innate immunity.ptember 23, 2011 ª2011 Elsevier Inc. 321
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